Ascentage Pharma Group International income statement data for the quarter ended Jun 2026. This income statement covers 5 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2023 | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|
| Additional items | |||||
| Shares Outstanding | 70.57M | 75.52M | 75.52M | 89.03M | 89.03M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 72.55M | 87.07M | 93.33M |